『Medscape InDiscussion: Psoriasis』のカバーアート

Medscape InDiscussion: Psoriasis

Medscape InDiscussion: Psoriasis

著者: Medscape
無料で聴く

Listen to Medscape InDiscussion: Psoriasis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep1-2026a1000511). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.Copyright 2026, Medscape 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Can Diet Improve Psoriasis Outcomes?
    2026/07/23

    Many patients ask whether changing what they eat can help their psoriasis. Dr Joel Gelfand reviews the MEDIPSO trial and explains when a Mediterranean diet may meaningfully improve disease severity.

    Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep6-2026a10006hq. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Psoriasis https://emedicine.medscape.com/article/1943419-overview

    Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/40991259/

    Evaluating Psoriasis With Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment https://pubmed.ncbi.nlm.nih.gov/15389191/

    International Psoriasis Council https://psoriasiscouncil.org/

    Mediterranean Diet and Cardiovascular Health: Teachings of the PREDIMED Study https://pubmed.ncbi.nlm.nih.gov/24829485/

    Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/39319513/

    PCORI — Patient-Centered Outcomes Research Institute https://www.pcori.org/

    Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies https://pubmed.ncbi.nlm.nih.gov/23425140/

    Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial https://pubmed.ncbi.nlm.nih.gov/29776990/

    The Health Benefits of UV Radiation Exposure Through Vitamin D Production or Non-Vitamin D Pathways. Blood Pressure and Cardiovascular Disease https://pubmed.ncbi.nlm.nih.gov/28009890/

    Using Guidelines of Care to Lower Cardiovascular Risk in Patients With Psoriasis https://pubmed.ncbi.nlm.nih.gov/38796273/

    Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis (CP3) Study: Preliminary Results https://www.med.upenn.edu/gelfand/assets/user-content/documents/cp3-isidposter2023-an.pdf


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    続きを読む 一部表示
    25 分
  • Can AI Cut Your Psoriasis Admin Hours in Half?
    2026/06/25
    Dr Faranak Kamangar joins Dr Steven Feldman to discuss how AI tools are cutting psoriasis admin hours, improving diagnostic accuracy, and freeing clinicians for more patient-facing care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep5-2026a10006hn. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.  Resources Psoriasis https://emedicine.medscape.com/article/1943419-overview DermGPT https://www.dermgpt.com/ PSO Telehealth https://www.psotelehealth.com/ The Future of Dermatology https://thefutureofdermatology.podbean.com/ Evaluating Psoriasis With Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician’s Global Assessment https://pubmed.ncbi.nlm.nih.gov/15389191/ Functional Genomics in Psoriasis https://pubmed.ncbi.nlm.nih.gov/39000456/ Psoriatic Arthritis https://emedicine.medscape.com/article/2196539-overview Image-Based Artificial Intelligence in Psoriasis Assessment: The Beginning of a New Diagnostic Era? https://pubmed.ncbi.nlm.nih.gov/39259262/ Automated Triage of Cancer-Suspicious Skin Lesions With 3D Total-Body Photography https://pubmed.ncbi.nlm.nih.gov/41272121/ Current Therapeutic Overview and Future Perspectives Regarding the Treatment of Psoriasis https://pubmed.ncbi.nlm.nih.gov/39405929/ Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum https://pubmed.ncbi.nlm.nih.gov/37115527/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
    続きを読む 一部表示
    21 分
  • How Confident Should We Be in Psoriasis Biosimilars?
    2026/05/27

    Join Drs Steven Feldman and Jonathan Kay as they examine the data on safety, switching, and confidence in psoriasis biosimilars.

    Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep4-2026a10006hl. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Psoriasis https://emedicine.medscape.com/article/1943419-overview

    Lyme Disease https://emedicine.medscape.com/article/330178-overview

    Synovial Fluid Eosinophilia in Lyme Disease https://pubmed.ncbi.nlm.nih.gov/3056421/

    Rheumatoid Arthritis (RA) Treatment & Management https://emedicine.medscape.com/article/331715-treatment

    Psoriatic Arthritis Treatment & Management https://emedicine.medscape.com/article/2196539-treatment#d9

    A Review of Biosimilars for Rheumatoid Arthritis https://pubmed.ncbi.nlm.nih.gov/35552095/

    Drift, Evolution, and Divergence in Biologics and Biosimilars https://pubmed.ncbi.nlm.nih.gov/24567263/

    FDA Updates Guidance on Interchangeability https://www.fda.gov/drugs/drug-alerts-and-statements/fda-updates-guidance-interchangeability

    Preclinical Rheumatoid Arthritis and Rheumatoid Arthritis Prevention https://pubmed.ncbi.nlm.nih.gov/32205569/

    Physicochemical and Biological Similarity Assessment of LBAL, a Biosimilar to Adalimumab Reference Product (Humira®) https://pubmed.ncbi.nlm.nih.gov/34262661/

    GP2017, an Adalimumab Biosimilar: Pharmacokinetic Similarity to Its Reference Medicine and Pharmacokinetics Comparison of Different Administration Methods https://pubmed.ncbi.nlm.nih.gov/30698045/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    続きを読む 一部表示
    20 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません